Evidence map›Paper›PMID 24288233›Full record

ArticleJournal of biomedical materials research. Part A2014

Effects of nanoporous alumina on inflammatory cell response.

Shiuli Pujari, Andreas Hoess, Jinhui Shen, Annika Thormann, Andreas Heilmann, Liping Tang, Marjam Karlsson-Ott

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Nanomaterials, inflammation, and tissue engineering.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
  9. Principles of Biocompatible Nanotube Design for High-Performance Biomaterials.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Shiuli PujariApplied Material Science, Department of Engineering Sciences, The Ångström Laboratory, Uppsala University, SE-751 21, Uppsala, Sweden.
Andreas Hoess
Jinhui Shen
Annika Thormann
Andreas Heilmann
Liping Tang
Marjam Karlsson-Ott
Uppsala University · SEFraunhofer Institute for Mechanics of Materials · DEThe University of Texas at Arlington · US

Funding

Biomaterial-mediated fibrotic responsesR01EB007271 · NIBIB · UNIVERSITY OF TEXAS ARLINGTON · PI TANG, LIPING · 2008 to 2011
$1.4M
NIBIB NIH HHS EB007271NIBIB NIH HHS R01 EB007271
6 · The paper itself

Abstract

The present study focuses on the effects of nanoscale porosity on inflammatory response in vitro and in vivo. Nanoporous alumina membranes with different pore sizes, 20 and 200 nm in diameter, were used. We first evaluated cell/alumina interactions in vitro by observing adhesion, proliferation, and activation of a murine fibroblast and a macrophage cell line. To investigate the chronic inflammatory response, the membranes were implanted subcutaneously in mice for 2 weeks. Cell recruitment to the site of implantation was determined by histology and the production of cytokines was measured by protein array analysis. Both in vitro and in vivo studies showed that 200 nm pores induced a stronger inflammatory response as compared to the alumina with 20 nm pores. This was observed by an increase in macrophage activation in vitro as well as higher cell recruitment and generation of proinflammatory cytokines around the alumina with 200 nm pores, in vivo. Our results suggest that nanofeatures can be modulated in order to control the inflammatory response to implants.

Indexed as

Materials TestingNanoporesAluminum OxideAnimalsFibroblastsInflammationMacrophagesMiceNIH 3T3 CellsAluminum Oxideinflammationin vivonanofeaturesnanoporous alumina

Identifiers

PMID24288233
PMCPMC4038668
OpenAlexW1557396770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.